Phenomix: Clinical Trials

8 terminated, 2 completed, 1 unknown. 8 Phase 3, 3 Phase 2.

By phase and status

Phase	Trials	Status
Phase 3	8	Terminated 7, Completed 1
Phase 2	3	Completed 1, Terminated 1, Unknown 1

Follow Phenomix: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone Dutogliptin, Sitagliptin - Diabetes Mellitus, Type 2	Phase 3	Terminated	Forest Laboratories	141	2010-03-01	2011-09-21
Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin dutogliptin, sitagliptin - Type 2 Diabetes Mellitus	Phase 3	Terminated	Phenomix	650	2009-11-01	2010-08-11
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone Placebo, Dutogliptin - Diabetes Mellitus, Type II	Phase 3	Terminated	Forest Laboratories	252	2009-08-01	2011-09-21
Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment dutogliptin, placebo, sitagliptin - Type 2 Diabetes Mellitus, Renal Impairment	Phase 3	Terminated	Phenomix	360	2009-08-01	2010-02-03
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin Dutogliptin, Placebo - Diabetes Mellitus, Type II	Phase 3	Terminated	Forest Laboratories	677	2009-07-01	2011-09-21
Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin dutogliptin, placebo - Type 2 Diabetes Mellitus	Phase 3	Terminated	Phenomix	700	2009-05-01	2010-08-11
Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus dutogliptin - Type 2 Diabetes Mellitus, Type 2 Diabetes	Phase 3	Terminated	Phenomix	450	2009-03-01	2010-08-11
Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus PHX1149T, Placebo - Type 2 Diabetes Mellitus	Phase 3	Completed	Phenomix	480	2008-07-01	2010-04-13
Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus dutogliptin - Type 2 Diabetes Mellitus	Phase 2	Terminated	Phenomix	339	2007-07-01	2010-08-11
A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus PHX1149T - Type 2 Diabetes Mellitus	Phase 2	Unknown	Phenomix	400	2007-04-01	2009-06-08
Randomized, Double-Blind, Placebo-Controlled, With PHX1149 in Patients With Type 2 Diabetes Mellitus PHX1149 - Type 2 Diabetes Mellitus	Phase 2	Completed	Phenomix	180	2006-04-01	2007-09-18

Conditions studied

Diabetes Mellitus, Type 2 (11)  ·  Diabetes Mellitus (5)  ·  Renal Insufficiency (1)

Interventions

dutogliptin (9)  ·  Sitagliptin Phosphate (3)

Countries

United States (11)  ·  India (8)  ·  Argentina (6)  ·  Peru (5)  ·  Romania (4)  ·  Ukraine (3)  ·  Belarus (2)  ·  Canada (2)  ·  Czechia (2)  ·  Lithuania (2)  ·  Malaysia (2)  ·  Mexico (2)  ·  Philippines (2)  ·  Poland (2)  ·  Chile (1)

Top investigators

Kaity Posada, PharmD (3)  ·  Hans-Peter Guler, MD (2)